Skip to Main Content

Paper Details

A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens.
EBioMedicine
35
2021
COVID-19, SARS, SARS-CoV-2, SARS-CoV-2 antigen, SARS-CoV-2 viral antigen, coronavirus 2, nucleocapsid protein, patients, pure microbial cultures, severe acute respiratory syndrome
Author NameAffiliation
Surendra DasariMayo Clinic
Ravinder J SinghDivision of Clinical Biochemistry and Immunology, Mayo Clinic
Akhilesh PandeyDivision of Clinical Biochemistry and Immunology, Mayo Clinic, USA Center for Individualized Medicine, USA Center for Molecular Medicine, National Institute of Mental Health and Neurosciences
  • 1 - 3

Datasets

Release 1.2